🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1715)
All (1715)
Buys (205)
Sells (1510)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Travere Therapeutics, Inc.
(TVTX)
Heerma Peter
— EVP, CHIEF COMMERCIAL OFFICER
Sep 17, 2026
Sale
Shares
8,282
Price
$65.07
Total Value
$538.92K
Shares Held After
117,066
% of Holdings
6.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Canopy Growth Corp
(CGC)
Stewart Thomas Carlton
— Chief Financial Officer and Chief Accounting Officer
Sep 17, 2026
Sale
Shares
25,755
Price
$0.93
Total Value
$23.95K
Shares Held After
588,412
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Caris Life Sciences, Inc.
(CAI)
Brille Brian J
— Director
Sep 17, 2026
Sale
Shares
400,000
Price
$30.33
Total Value
$12.13M
Shares Held After
230,303
% of Holdings
63.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dogecoin Cash, Inc.
(CBDS)
TOBIAS DAVID
— Director
Sep 17, 2026
Sale
Shares
180,000
Price
$0.01
Total Value
$1.80K
Shares Held After
23,615,742
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Sep 16, 2026
Sale
Shares
1,654
Price
$153.24
Total Value
$253.46K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Sep 16, 2026
Sale
Shares
989
Price
$152.36
Total Value
$150.69K
Shares Held After
1,654
% of Holdings
37.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PALVELLA THERAPEUTICS, INC.
(PVLA)
Goin Kathleen
— Chief Operating Officer
Sep 16, 2026
Sale
Shares
1,659
Price
$151.16
Total Value
$250.77K
Shares Held After
2,643
% of Holdings
38.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
REVVITY, INC.
(RVTY)
Vohra Tajinder S
— Senior Vice President, Global Operations
Sep 16, 2026
Sale
Shares
7,330
Price
$140.88
Total Value
$1.03M
Shares Held After
6,635
% of Holdings
52.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcutis Biotherapeutics, Inc.
(ARQT)
Matsuda Masaru
— Reporting Person's title: EVP, Chief Legal Officer
Sep 16, 2026
Sale
Shares
3,674
Price
$25.00
Total Value
$91.85K
Shares Held After
112,508
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
Fukushima Ryan
— CEO, Data
Sep 16, 2026
Sale
Shares
700
Price
$70.00
Total Value
$49.00K
Shares Held After
15,874
% of Holdings
4.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
LO FRANCIS
— Chief People Officer
Sep 16, 2026
Sale
Shares
7,869
Price
$28.57
Total Value
$224.82K
Shares Held After
220,867
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
LO FRANCIS
— Chief People Officer
Sep 16, 2026
Sale
Shares
107,537
Price
$28.02
Total Value
$3.01M
Shares Held After
228,736
% of Holdings
32.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CORCEPT THERAPEUTICS INC
(CORT)
Vieira Roberto Wandenkolk
— President, Oncology
Sep 16, 2026
Sale
Shares
296
Price
$100.82
Total Value
$29.84K
Shares Held After
3,946
% of Holdings
7.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Skye Bioscience, Inc.
(SKYE)
Schwab Andrew J.
— Director
Sep 16, 2026
Sale
Shares
1,285
Price
$1.91
Total Value
$2.45K
Shares Held After
5,616
% of Holdings
18.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Skye Bioscience, Inc.
(SKYE)
Schwab Andrew J.
— Director
Sep 16, 2026
Sale
Shares
32,607
Price
$1.91
Total Value
$62.28K
Shares Held After
142,463
% of Holdings
18.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Mancini Anthony
— Chief Global Commercialization Officer
Sep 16, 2026
Sale
Shares
1,747
Price
$199.30
Total Value
$348.18K
Shares Held After
42,116
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Mancini Anthony
— Chief Global Commercialization Officer
Sep 16, 2026
Sale
Shares
27
Price
$195.05
Total Value
$5.27K
Shares Held After
43,863
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Kelsey Stephen Michael
— Senior Advisor to the Chief Executive Officer
Sep 16, 2026
Sale
Shares
5,484
Price
$199.30
Total Value
$1.09M
Shares Held After
286,307
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Sandler Alan B.
— Chief Development Officer
Sep 16, 2026
Sale
Shares
336
Price
$199.30
Total Value
$66.97K
Shares Held After
52,868
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Kelsey Stephen Michael
— Senior Advisor to the Chief Executive Officer
Sep 16, 2026
Sale
Shares
85
Price
$195.01
Total Value
$16.58K
Shares Held After
291,791
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Sandler Alan B.
— Chief Development Officer
Sep 16, 2026
Sale
Shares
5
Price
$194.96
Total Value
$974.79
Shares Held After
53,204
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Horn Margaret A
— Chief Operating Officer
Sep 16, 2026
Sale
Shares
4,891
Price
$199.30
Total Value
$974.79K
Shares Held After
149,680
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Horn Margaret A
— Chief Operating Officer
Sep 16, 2026
Sale
Shares
76
Price
$195.01
Total Value
$14.82K
Shares Held After
154,571
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Cislini Jeff
— SVP&General Counsel
Sep 16, 2026
Sale
Shares
3,314
Price
$199.30
Total Value
$660.49K
Shares Held After
52,541
% of Holdings
5.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Cislini Jeff
— SVP&General Counsel
Sep 16, 2026
Sale
Shares
52
Price
$195.01
Total Value
$10.14K
Shares Held After
55,855
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
GOLDSMITH MARK A
— Director
Sep 16, 2026
Sale
Shares
13,775
Price
$199.30
Total Value
$2.75M
Shares Held After
253,342
% of Holdings
5.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Anders Jack
— Chief Financial Officer
Sep 16, 2026
Sale
Shares
3,992
Price
$199.30
Total Value
$795.62K
Shares Held After
119,216
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
GOLDSMITH MARK A
— Director
Sep 16, 2026
Sale
Shares
213
Price
$195.01
Total Value
$41.54K
Shares Held After
267,117
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Revolution Medicines, Inc.
(RVMD)
Anders Jack
— Chief Financial Officer
Sep 16, 2026
Sale
Shares
61
Price
$195.00
Total Value
$11.89K
Shares Held After
123,208
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
SCHMERTZLER MICHAEL
— Director
Sep 16, 2026
Sale
Shares
7,006
Price
$67.35
Total Value
$471.85K
Shares Held After
1,306,594
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
SCHMERTZLER MICHAEL
— Director
Sep 16, 2026
Sale
Shares
2,994
Price
$66.58
Total Value
$199.34K
Shares Held After
1,313,600
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Harmony Biosciences Holdings, Inc.
(HRMY)
Budur Kumar
— CHIEF MEDICAL OFFICER
Sep 16, 2026
Sale
Shares
1,800
Price
$43.01
Total Value
$77.43K
Shares Held After
13,115
% of Holdings
12.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
4
Price
$172.00
Total Value
$688.00
Shares Held After
72,433
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
234
Price
$170.95
Total Value
$40.00K
Shares Held After
72,437
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
120
Price
$168.38
Total Value
$20.21K
Shares Held After
72,671
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
460
Price
$167.32
Total Value
$76.97K
Shares Held After
72,791
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
191
Price
$166.20
Total Value
$31.74K
Shares Held After
73,251
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
345
Price
$164.60
Total Value
$56.79K
Shares Held After
73,442
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GLAUKOS Corp
(GKOS)
Navratil Tomas
— CHIEF DEVELOPMENT OFFICER
Sep 16, 2026
Sale
Shares
103
Price
$163.20
Total Value
$16.81K
Shares Held After
73,787
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
TELA Bio, Inc.
(TELA)
Capper Joseph H
— Director
Sep 16, 2026
Purchase
Shares
50,000
Price
$1.17
Total Value
$58.27K
Shares Held After
154,827
% of Holdings
32.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Avalo Therapeutics, Inc.
(AVTX)
Sullivan Christopher Ryan
— Chief Financial Officer
Sep 16, 2026
Sale
Shares
12,394
Price
$16.33
Total Value
$202.44K
Shares Held After
39,900
% of Holdings
23.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MapLight Therapeutics, Inc.
(MPLT)
Hanson Kristopher
— General Counsel
Sep 16, 2026
Sale
Shares
16,509
Price
$11.67
Total Value
$192.66K
Shares Held After
137,044
% of Holdings
10.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Bispham Barbara Harlin
— General Counsel and Corporate Secretary.
Sep 16, 2026
Sale
Shares
620
Price
$17.90
Total Value
$11.10K
Shares Held After
18,710
% of Holdings
3.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Scalzo Richard William
— Chief Financial Officer
Sep 16, 2026
Sale
Shares
568
Price
$17.90
Total Value
$10.17K
Shares Held After
19,730
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Im Ellie Eunkyung
— Chief Medical Officer
Sep 16, 2026
Sale
Shares
623
Price
$17.90
Total Value
$11.15K
Shares Held After
21,446
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Pinkas Jan
— Chief Scientific Officer
Sep 16, 2026
Sale
Shares
658
Price
$17.90
Total Value
$11.78K
Shares Held After
21,581
% of Holdings
3.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Brumm Joshua T
— Director
Sep 16, 2026
Sale
Shares
1,610
Price
$17.90
Total Value
$28.82K
Shares Held After
279,602
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
McNeill Jonathan
— President and COO
Sep 16, 2026
Sale
Shares
731
Price
$17.90
Total Value
$13.08K
Shares Held After
138,427
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CRESCENT BIOPHARMA, INC.
(CBIO)
Lynch Ryan
— Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Sep 16, 2026
Sale
Shares
240
Price
$17.90
Total Value
$4.30K
Shares Held After
13,631
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ICON PLC
(ICLR)
CLIMAX JOHN DR
— Director
Sep 16, 2026
Sale
Shares
5,005
Price
$175.00
Total Value
$875.88K
Shares Held After
2,087
% of Holdings
70.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 51–100 of 1715 transactions (page 2 of 35)
Version: v26.9.1